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Abstract Previous studies have reported associations of
polymorphisms in the IGF1 gene with phenotypes of body
composition (BC). The purpose of this study was to identify
phenotypes of BC and physical function that were associated with the IGF1 promoter polymorphism (rs35767,
-C1245T). Subjects from the Health, Aging, and Body
Composition Study, white males and females (n = 925/836)
and black males and females (533/705) aged 70–79 years
were genotyped for the polymorphism. Phenotypes of
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muscle size and function, bone mineral density, and BC
were analyzed for associations with this polymorphism. To
validate and compare these findings, a cohort of young
(mean age = 24.6, SD = 5.9) white men and women
(n = 173/296) with similar phenotypic measurements were
genotyped. An association with BC was identified in elderly
females when significant covariates (physical activity, age,
smoking status, body mass index) were included. White
women with C/C genotype had 3% more trunk fat and 2%
more total fat than those with C/T (P \ 0.05). Black women
with C/C genotype had 3% less total lean mass and 3% less
muscle mass than their T/T counterparts (P \ 0.05). Associations were identified with muscle strength in white
women (P \ 0.01) that were in agreement with the C/C
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genotype having lower muscle function. Thus, in an elderly
population but not a young population, a polymorphism in
the IGF1 gene may be predictive of differences in body
composition, primarily in black females.
Keywords IGF1  Muscle  Body composition 
Bone mineral density  Elderly  SNP
Introduction
IGF1 is known to be necessary and sufficient in promoting
muscle growth and development (Coleman et al. 1995;
Powell-Braxton et al. 1993; Gonzalez et al. 2003; Greig
et al. 2006; Bamman et al. 2007). In the search for genomic
regions that regulate muscle growth and repair over the
human life span, genome wide association studies are often
employed. The few studies that have examined muscle
function as a variable have found that a region near IGF1
on chromosome 12 appears to be one of the most influential
(Sun et al. 1999; Chagnon et al. 2001). This region, in the
vicinity of the promoter of IGF1 has been studied extensively and seems likely to play a role in at least circulating
IGF1 levels (Frayling et al. 2002; Rietveld et al. 2003;
Rosen et al. 1998), though not all studies agree with these
results (Missmer et al. 2002; Kim et al. 2002). Only two
studies have examined a polymorphism in this region
specifically as it relates to muscle strength in humans, and
in both cases the elderly. While an association was found
the functionality of that polymorphism is currently
unknown (Kostek et al. 2005; Hand et al. 2007). Due to the
nature of a dinucleotide repeat (CA) such as the aforementioned, haplotypes will be difficult to establish; thus
there is a need to study SNPs in this region to identify
associations before haplotypes can be examined.
Recently, other polymorphisms in the promoter region of
IGF1 have gained attention (Cheng et al. 2006; Canzian
et al. 2006; Tamimi et al. 2007; Hernandez et al. 2007). Two
studies examining prostate cancer risk in either a multiethnic
cohort or an African-American population demonstrate that
the rs7965399 SNP is associated with cancer risk and circulating levels of IGF1(Cheng et al. 2006; Hernandez et al.
2007). Additionally, in the Nurses’ Health Study an
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association was found between rs35767 IGF1 promoter SNP
and mammographic density, which is relevant because
mammographic density is known to be under partial control
of IGF1 levels (Tamimi et al. 2007). In the EPIC study of
breast cancer, the rs35767 SNP in the promoter of IGF1 was
associated with blood levels of IGF1 and breast cancer risk
(Canzian et al. 2006). In terms of muscle function, our
preliminary analysis suggested that the rs35767 was associated with skeletal muscle phenotypes in a younger (18–
34 years) population, yet the sample size was small and a
validation cohort was not available at the time of the study
(Devaney et al. 2004). With the known decrease of IGF1
levels with increasing age and impact of IGF1 on measures
of BC and muscle function, we sought to examine the
association of this SNP with BC in an older population and
to reanalyze our younger population using the entire
Caucasian cohort. The rationale being that if IGF1 genotype
were predictive of BC changes with aging that were detrimental to health, early intervention programs could be more
efficiently targeted in these individuals. If the BC/genotype
associations were present at an early adult age, interventions
could begin early but if the associations were only present in
the elderly it would need to be determined when in the aging
process these associations become relevant. We hypothesized that an association would exist in phenotypes known to
be controlled by IGF1.

Methods
The current study analyzed data from two separate prospective studies, Health, Aging, and Body Composition
(Health ABC), and Functional SNPs associated with
human Muscle Size and strength (FMS). The Health ABC
study recruited 3,075 participants from the Pittsburgh, PA
and Memphis, TN metropolitan areas. Participants were
men and women between the ages of 70–79 years of whom
48.4% were women and 41.7% black. Participants selfreported having no difficulty walking  mile, climbing 10
stairs, or performing basic activities of daily living. All
participants were free of life-threatening illness and did not
plan to move from the area for at least 3 years. The study
protocol was approved by the Institutional Review Boards
of the University of Tennessee, Memphis and the University of Pittsburgh, and each participant provided written
informed consent for participation.
Health ABC
Body composition
Body weight and height were measured without shoes in a
hospital gown on a calibrated balance-beam scale and
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stadiometer. BMI was calculated as kg of body weight/
height in m2. Lean total body mass was assessed using
DEXA (Hologic QDR 4500 software version 8.21). Total
lean mass was defined as measured lean mass plus bone
mineral content (Visser et al. 1999). Trunk fat and
appendicular fat were determined as previously described
(Visser et al. 2003). Total body fat mass and percent body
fat were also measured (Park et al. 2006).
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utilizing two tests, which have been described in detail
previously (Taaffe et al. 2000). Briefly, the test battery is
an extension of the lower-extremity performance tests used
in the Epidemiologic Studies of the Elderly (EPESE)
(Brach et al. 2004) and includes five repeated chair stands
and gait speed assessment. Gait speed was assessed over a
20-m straight course (Atkinson et al. 2007).
FMS

Strength assessments
All strength measures have been reported previously (Park
et al. 2006). Briefly, knee extension strength was measured
using an isokinetic dynamometer (125 AP; Kin-Com,
Chattanooga, TN) and an isometric dynamometer was used
(Jaymar; JLW Instruments, Chicago, IL) for grip strength. For
knee extension, maximal voluntary concentric isokinetic
torque was assessed at an angular velocity of 60°s-1. At least
three, but no more than six, maximal efforts were allowed and
the mean maximal torque was recorded and used for the
analysis. Isometric grip strength was assessed for each hand.
The vast majority (96%) who had leg strength testing also had
grip strength testing. For these analyses, we used the maximum of the force from two trials for the right upper extremity.

Details of the FMS population have been previously reported
(Thompson et al. 2004). Briefly, FMS was a multicenter prospective study to examine associations of muscle size and
function with genotype. Subjects were recruited to participate
in a progressive resistance training program lasting 12 weeks.
Each subject had MRIs of the upper arms to analyze muscle,
bone, and fat. All measures were collected at baseline and the
data were utilized in the current cross-sectional analysis. DNA
samples were extracted from whole blood by standard lysis
conditions and stored until analysis. Respective institutional
review boards at each site approved the study protocol, and all
subjects read and signed an informed consent document.
Maximal isometric contraction test [maximal voluntary
contraction (MVC)]

CT
Skeletal muscle composition assessed via CT (9800
Advantage, General Electric, Milwaukee, WI, Somatom
Plus 4, Siemens, Erlangen, Germany and PQ 2000S,
Marconi Medical Systems, Cleveland, OH) has been
described previously (Goodpaster et al. 2001). Briefly, to
localize the mid-thigh position, a scout scan was obtained.
The scan position was determined as the midpoint of the
distance between the medial edge of the greater trochanter
and the intercondyloid fossa of the right leg. A single
10-mm slice (120 kVp and 200–250 mA) was obtained at
the femoral midpoint. All images were analyzed by a single
observer. Proprietary software using the IDL development
platform (RSI Systems, Boulder, CO) was utilized to calculate skeletal muscle and area of the thigh. Subcutaneous
adipose tissue area was distinguished from intermuscular
adipose tissue area by manually drawing a line along the
deep fascial plane surrounding the thigh muscles. Once the
adipose tissue was identified, the individual muscles were
measured utilizing manual tracing. The total area of nonadipose, nonbone tissue within the deep fascial plane was
used as a measure of muscle area.

MVC of the elbow flexors was tested at baseline on a specially designed and modified preacher bench using a strain
gauge attached to a strength evaluation system (model
32628CTL; Lafayette Instrument Co., Lafayette, IN).
Baseline isometric testing was performed over 3 days, separated by no more than 48 h. The average of the 2nd and 3rd
testing days was used as the baseline criterion measurement.
Subjects were positioned with their arms at a 90° angle at the
medial epicondyle in line with the axis of rotation of the
bench. Three tests lasting 3 s were performed on each arm,
all separated by a 1-min rest period. The three peak force
values were averaged for each testing day.
One-repetition maximum (1RM) testing
A 1-RM protocol as previously reported (Thompson et al.
2004) was used to measure dynamic strength of the elbow
flexors on a standard preacher bench. Two warm-up sets were
completed at 50 and 75% of the predicted 1RM for eight repetitions and five repetitions, respectively. Single attempts were
performed until one single repetition with full-range of motion
was completed, which was recorded and used for analysis.

Physical function

Volumetric measurements

Physical function as related to muscle strength was determined from the Health ABC physical function test battery

MRI was used to assess whole muscle, subcutaneous fat,
and cortical bone volume of each arm. Baseline MRI scans
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were performed before or 48 h after any isometric or 1RM
testing. Rapidia, a personal computer-based, three-dimensional, interactive system for viewing images from computerized tomography and MRI scans (3D Med Co. Ltd.,
Seoul, Republic of Korea), was used for all volumetric
measurements. Six slices from each image were analyzed
using the metaphyseal-diaphyseal junction landmark,
making sure the same regions were measured from pre- and
post-images. Cortical bone, subcutaneous fat, and muscle
were isolated using image signal intensity differences
between tissues, and once the region of interest was segmented, total volume was taken for the six evaluated slices.
Repeatability and reliability of Rapidia volume measurements were verified using a phantom of known volume.
Genotyping
For FMS, blood samples were obtained from all individuals
in EDTA anticoagulant, sent to the coordinating site in
Washington, DC, without subject identification, and DNA
was isolated using QIAGEN kits (QIAGEN, Valencia,
CA). For Health ABC, Genomic DNA was extracted from
the buffy coat layer of whole blood using the PURE-GENE
DNA Purification Kit (Gentra System, Inc., Minneaapolis,
MN, USA), and stored at -80°C until analysis. Genotypes
for the IGF1 -C1245T variant (rs35767) in this paper were
obtained with the use of a TaqMan allelic discrimination
assay that employs the 50 nuclease activity of Taq polymerase to detect a fluorescent reporter (VIC and FAM)
signal-generated during polymerase chain reactions (see
Supplementary material). For this study, we use two
methods of quality control for genotyping: the use of
negative controls and genotyping of replicate samples (at
least 5% of total). Replicate samples are checked and if
there is not a match then the genotyping is repeated.
Genotype analysis is performed using the latest version of
the 7900HT Sequence Detection Software (SDS v2.3) and
confirmed by manually by the technician.

Eur J Appl Physiol (2010) 110:315–324

comparing mean phenotype values among genotypes were
conducted and resulting P-values were adjusted for multiple comparisons using the Sidak method. Analyses were
conducted using Stata V9 (College Station, TX). Associations were considered to be statistically significant if the
nominal P value was less than 0.05.
For FMS, due to the low percentage of participants
representing other ethnic groups, all analyses were performed in whites, which accounted for *80% of the total
study population. Four size/strength phenotypes were
analyzed as continuous quantitative traits (Table 2). Normality of each quantitative trait was confirmed using the
Shapiro–Wilk normality test. Bivariate analyses of each
quantitative measurement showed several significant correlations with both age and baseline body mass; therefore,
associations between IGF1 and size/strength phenotypes
were assessed using analysis of covariance methods. Due
to large gender differences in baseline values, all analyses
were performed separately for men and women, using
generalized linear regression models which included age
and/or baseline body mass as covariates. Adjusted least
square means were derived from each model. Pair-wise
linear tests comparing mean phenotype values among
genotypes were conducted and resulting P values were
adjusted for multiple comparisons using the Sidak method.
Analyses were conducted using Stata V9 (College Station,
TX). Associations were considered to be statistically significant in the nominal P value was less than 0.05.
For both populations, the proportion of variance in
muscle size/strength measurements attributable to IGF1
genotype was determined by likelihood ratio tests comparing full (genotype and covariates) to constrained
(covariates only) models. Hardy–Weinberg equilibrium
was determined for IGF1 SNP using a chi-square test to
compare the observed genotype frequencies to those
expected under Hardy–Weinberg equilibrium.

Results
Statistical analyses
Subject characteristics
For Health ABC, covariates collected at baseline, which
are known correlates of muscle size and function were
examined for associations with the phenotypic variables of
interest by bivariate analysis (age, smoking history, physical activity, BMI, and reported disease (CAD, Cancer,
COPD, Diabetes)). Statistically significant covariates were
included in generalized linear regression models. Twelve
size/strength phenotypes were analyzed as continuous
quantitative traits (Table 2). Adjusted least square means
were derived from a general linear model adjusting for
age, smoking history, physical activity, BMI, and disease/
health status (as indicated above). Pair-wise linear tests
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A total of 2,999 subjects from the Health ABC study and
483 subjects from the FMS study were genotyped for the
IGF1 promoter, rs35767 SNP. For the Health ABC study,
1,761 white and 1,238 black participants were genotyped.
Participant’s genotype data for rs35767 data are presented
in Table 1. Allele and genotype frequencies did not differ
significantly from Hardy–Weinberg expectations and were
similar to those reported previously (Cheng et al. 2006;
Hernandez et al. 2007). IGF1 genotypes of Health ABC
participants did not differ significantly by gender, but a
significant difference did exist based on race (P \ 0.001),
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Table 1 Participant characteristics of the Health, Ageing, and Body Composition (Health ABC) study and Functional Polymorphisms Associated with Human Muscle Size and Strength (FMS) study
Health ABC
N

Age

FMS
Genotype (N)

N

CC

CT

TT

Age (SD)

Genotype (N)
CC

CT

TT

Black
Male

533

73.5 (2.8)

157

271

105

–

–

–

–

–

Female

705

73.4 (3.0)

238

336

131

–

–

–

–

–

Male

925

73.9 (2.8)

621

279

25

184

23.8 (5.8)

123

47

14

Female

836

73.6 (2.8)

567

238

31

299

24.1 (5.8)

170

96

33

White

Age is mean years (SD)

though this was expected due to different allele frequencies
between the populations. The black and white participants
of Health ABC were not significantly different based on
age or BMI. For the FMS cohort, 483 subjects were genotyped. At the time of analysis, the white ethnic grouping
made up *80% of FMS participants; thus other ethnic
groups did not allow realistic statistical comparisons to the
phenotypes of interest. The average age of FMS subjects
was 24 (SD 5.9) years and did not differ significantly
between sexes. For rs35767 in the FMS cohort, genotype
did not differ by sex but allele/genotype frequencies did
differ from Hardy–Weinberg expectations (P \ 0.0001).
Genotype/phenotype association
The primary association analysis conducted in the Health
ABC study was 12 total phenotypes (Table 2) related to
BC. Total number of subjects differed slightly for analysis
purposes due to data that were unavailable for some subjects (Supplemental Table 1). The bivariate analyses
between phenotypes and covariates (age, smoking, physical
activity, and BMI) revealed significant positive associations (P \ 0.01); thus phenotypes (Table 2) were covaried
for these variables in the final regression model. Disease
status was not significant for every dependent variable but
was included in the analysis model when significant. The
covariate regression analysis revealed several significant
associations in Black Females including lean mass, % fat,
muscle area, and BMD. Both lean mass and muscle area
was lowest amongst the CC genotype group and significantly so when compared to the TT genotype group (2.7%,
P \ 0.05 and 3.1%, P \ 0.05, respectively (Table 3)).
Additionally, BMD was significantly lower (4.8%,
P \ 0.05) in the CC group compared to TT whilst % fat
was highest in the CC group (1.3%, P \ 0.05). In White
Females from Health ABC, trunk fat and total fat were
highest in the CC genotype group (2.6%, P \ 0.05; and
2.0%, P \ 0.05 respectively). White Males in the CC

genotype group scored significantly lower in the single
chair stand than those in the CT genotype group (4%,
P \ 0.05) while Black Males showed no significant associations with any of the measured phenotypes and the IGF1
polymorphism.
In the FMS cohort, only white females demonstrated a
significant association with any phenotype, 1-RM was
highest in the CT genotype group (12%, P \ 0.05 when
compared to the CC genotype; and 18%, P \ 0.05 when
compared to TT (Table 3)). No other associations were
found in the FMS cohort with the IGF1 polymorphism.
Table 3 emphasizes the positive associations found as all
phenotypes in Table 2 were analyzed, yet only those listed
in Table 3 were statistically significant.

Discussion
Here, we report the first association analysis of the IGF1
promoter SNP rs35767 with body composition and muscle
function. In two separate cohorts, the CC genotype of
rs35767 was associated with phenotypes that may represent
a reduced function of IGF1. Contrary to our original
hypothesis, the majority of associations were not in muscle
function, yet were consistent based on genotype. The
association appears to be relevant specifically for older
black and possibly white women. In the Health ABC
cohort, rs35767 showed a significant association with
measures of adipose tissue, BMD, and muscle, in black
women. The CC genotype, in white women was associated
with an increase in trunk fat and total body fat, and in black
women with increased fat and decreased bone and muscle
volume. In FMS, only white men and women were analyzed due to sample size. White women displayed reduced
muscle strength with the CC or TT genotype with no other
associations found in the FMS cohort. With the known
biological function of IGF1 and the change of IGF1 that
occurs with aging, it seems likely that the rs35767 SNP
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Table 2 Adjusted means of all variables separated by race, gender, and genotype
Phenotype

White males genotype
CC

Maximal isokinetic effort (Nm)
20 m walk-time (km/s)

Black males genotype

CT

333.40 ± 4.60

TT

338.80 ± 6.65

CC

319.56 ± 22.59

CT

313.96 ± 10.49

TT

324.87 ± 8.34

297.92 ± 13.31

0.00016 ± 1.8e-6 0.00016 ± 2.7e-6 0.00017 ± 9.1e-6 0.000019 ± 2.9e-6 0.00019 ± 2.2e-6 0.00019 ± 3.6e-6

Single chair stand (s)
Grip strength (kg)

1.99 ± 0.02

2.07 ± 0.03

2.00 ± 0.10

2.13 ± 0.07

2.11 ± 0.05

2.15 ± 0.09

35.52 ± 0.31

35.37 ± 0.46

33.92 ± 1.60

38.87 ± 0.74

37.76 ± 0.56

37.45 ± 0.92

Trunk fat (g)

12779 ± 85

12781 ± 127

13159 ± 445

11056 ± 178

11136 ± 139

10966 ± 222

Trunk - lean ? BMC (g)

28669 ± 109

28325 ± 163

28021 ± 601

27642 ± 222

27855 ± 172

27859 ± 284

Total fat (g)

23773 ± 131

23808 ± 196

23869 ± 690

22430 ± 283

22309 ± 218

22178 ± 348

Total lean ? BMC (g)

57588 ± 207

57020 ± 307

55855 ± 1150

58890 ± 442

59009 ± 343

59005 ± 555

Total percent fat

28.68 ± 0.13

28.91 ± 0.20

29.32 ± 0.75

26.90 ± 0.29

26.84 ± 0.22

26.73 ± 0.36

127.65 ± 0.58

126.68 ± 0.87

123.09 ± 3.11

138.89 ± 1.41

138.39 ± 1.08

137.90 ± 1.74

Thigh muscle density (HU) (2 thigh
avg)

37.59 ± 0.22

37.02 ± 0.33

36.43 ± 1.19

36.78 ± 0.46

37.22 ± 0.35

37.29 ± 0.57

Total hip bone mineral density
(g/cm2)

0.943 ± 0.005

0.941 ± 0.008

0.936 ± 0.028

1.00 ± 0.01

1.02 ± 0.01

1.03 ± 0.01

Thigh muscle area (cm2) (2 thigh
avg)

White females
CC
Maximal isokinetic effort (Nm)
20 m walk-time (km/s)

Black females
CT

204.69 ± 3.44

TT

213.23 ± 5.35

CC

203.13 ± 14.83

CT

208.15 ± 5.12

TT

213.64 ± 4.31

206.92 ± 7.15

0.00018 ± 1.4e-6 0.00018 ± 2.2e-6 0.00017 ± 6.1e-6 0.00021 ± 3.9e-6 0.00021 ± 3.2e-6 0.00021 ± 5.2e-6

Single chair stand (s)
Grip strength (kg)

2.12 ± 0.03

2.07 ± 0.05

1.98 ± 0.15

2.34 ± 0.08

2.17 ± 0.07

2.37 ± 0.11

20.80 ± 0.22

20.58 ± 0.34

20.80 ± 0.91

22.48 ± 0.41

23.09 ± 0.34

23.00 ± 0.56

Trunk fat (g)

12512 ± 87

12197 ± 133

12332 ± 380

14203 ± 158

14410 ± 133

14083 ± 214

Trunk - lean ? BMC (g)

20298 ± 87

20093 ± 132

20260 ± 377

21343 ± 153

21421 ± 127

21838 ± 204

Total fat (g)

26591 ± 126

26065 ± 194

26523 ± 554

31227 ± 243

30139 ± 215

30627 ± 328
45379 ± 398

Total lean ? BMC (g)

40035 ± 159

39504 ± 242

40268 ± 682

44169 ± 296

44348 ± 247

Total percent fat

39.13 ± 0.15

38.97 ± 0.23

38.81 ± 0.66

40.44 ± 0.25

40.09 ± 0.21

39.15 ± 0.33

Thigh muscle area (cm2) (2 thigh avg)

85.14 ± 0.45

85.25 ± 0.69

87.04 ± 1.96

100.36 ± 0.92

100.75 ± 0.77

103.46 ± 1.25

Thigh muscle density (HU) (2 thigh avg)

34.55 ± 0.25

35.03 ± 0.39

34.96 ± 1.10

31.87 ± 0.42

32.30 ± 0.35

33.11 ± 0.57

0.86 ± 0.01

0.76 ± 0.01

0.78 ± 0.02

0.84 ± 0.01

0.86 ± 0.01

0.88 ± 0.01

Total hip bone mineral density (g/cm2)
Phenotype

White males
Genotype
CC

Baseline 1-RM strength (lbs)
Baseline isometric strength (arm) (Nm)

CT

TT

26.40 ± 0.52

27.32 ± 0.82

25.66 ± 1.52

144.89 ± 4.03

146.99 ± 6.57

133.69 ± 12.69

Baseline whole muscle volume (cm3)

555100 ± 11761

573880 ± 17936

495848 ± 36206

Baseline subQ fat volume (cm3)

174204 ± 7171

171346 ± 10935

175978 ± 22075

CT

TT

White females
CC
Baseline 1-RM strength (lbs)
Baseline isometric strength (arm) (Nm)

13.60 ± 0.28

15.28 ± 0.37

12.92 ± 0.62

69.47 ± 1.95

68.36 ± 2.62

74.15 ± 4.47

Baseline whole muscle volume (cm3)

445296 ± 11762

448483 ± 16785

450800 ± 31654

Baseline subQ fat volume (cm3)

260511 ± 5779

255906 ± 8246

253311 ± 15551

All means adjusted for age, smoking, kcal/kg/week and BMI
All means adjusted for age and body mass
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Table 3 Significant findings of bivariate analysis comparing IGF1 genotype to phenotypes related to body composition and muscle function
from Health ABC and FMS studies
Health ABC phenotype (FMS)

Genotype

P

CC

CT

TT

Total lean ? BMC (g)

44169 ± 296

44348 ± 247

45379 ± 398

0.0072

Total fat (%)
Thigh muscle area (cm2)

40.4 ± 0.3
100.4 ± .9

40.1 ± 0.2
100.8 ± .8

39.1 ± 0.3
103.5 ± 1.3

0.0351, 0.0352
0.0401, 0.0082

Total hip BMD (g/cm2)

0.84 ± 0.008

Black females

0.86 ± 0.007

0.88 ± 0.011

0.0041

White females
Trunk fat (g)

12512 ± 87

12197 ± 134

12332 ± 380

0.0483

Total fat (g)

26591 ± 126

26065 ± 194

26523 ± 554

0.0173

13.6 ± 0.3

15.28 ± 0.04

12.9 ± 0.62

0.0093, 0.00362

1.99 ± 0.02

2.07 ± 0.03

2.00 ± 0.10

0.0233

1-RM (lb)
White males
Single chair stand (s)
Black males
–

–

–

–

NS

Values are means adjusted for age, smoking history, total physical activity, BMI, and disease status (FMS adjusted for age and body mass)
3 CC significantly different than CT
2 CT significantly different than TT
1 CC significantly different than TT
NS No significant differences between genotypes

could explain some of the variability in these phenotypes
that occurs with aging, specifically in black women.
IGF1 is known to be necessary and sufficient in promoting muscle growth and development. Indeed, knockout
models have demonstrated the lack of IGF1 causing severe
lack of muscle development (Powell-Braxton et al. 1993).
Muscle-specific overexpression of IGF1 causes muscle
hypertrophy, and human studies report an increase in IGF1
in response to hypertrophy stimulating exercise (Coleman
et al. 1995; Gonzalez et al. 2003; Greig et al. 2006; Bamman
et al. 2007). In the search for target SNPs or genes related to
BC and muscle function, IGF1 is a likely target based on its
known function. Additionally, in the only studies to use
genome wide linkage to identify areas that may be influencing differences in muscle between individuals, the IGF1
locus has been consistently identified as one of the most
likely targets (Sun et al. 1999; Chagnon et al. 2001). The
known loss of muscle that occurs with aging coinciding with
decreasing levels of IGF1 with aging, makes the IGF1
promoter region an especially promising target for study as it
relates to aging and BC. Indeed, numerous studies have
examined the IGF1 promoter in the context of diseases that
may be controlled by IGF1 expression (Cheng et al. 2006;
Tamimi et al. 2007; Hernandez et al. 2007). Our current data
suggest that this polymorphism may have a functional
component. Yet based on genotype, we only report a small
difference in muscle function in young white women and a
difference in muscle size in older black women.

In a preliminary analysis of our data, it was suggested
that the rs35767 SNP was associated with muscle function
(Devaney et al. 2004). Our current data support the
hypothesis that a polymorphism in this gene may affect
phenotypes that are dependent upon IGF1 function, at least
in older black women. Polymorphisms in the IGF1 promoter, being previously examined, have been associated
with similar phenotypes to the current study that are under
at least some control of IGF1 (Cheng et al. 2006; Canzian
et al. 2006; Tamimi et al. 2007). The rs35767 SNP has
been associated with circulating levels of IGF1 (Canzian
et al. 2006; Palles et al. 2008). This variant is located in a
region that is conserved at [70% sequence identity
between human, dog, mouse, and rat. In addition, this
variant is predicted to disrupt a transcription factor binding
site based on our analysis (Conde et al. 2006). Therefore,
we predict that the C allele (or in this case the CC genotype) of rs35767 is associated with lower levels of IGF1 in
skeletal muscle, potentially leading to greater amounts of
adipose tissue and less skeletal muscle mass with aging.
The most applied or clinically relevant finding in the
current study is the almost exclusive association of
rs35767 and BC phenotypes in older women, primarily
black women. Both men and women exhibit a decreased
level of circulating IGF1 with aging (Velasco et al. 1998;
Baumgartner et al. 1999). This decrease in IGF1 correlates with the increase in adiposity and loss of muscle and
bone mass in men and women with increasing age.
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However, these changes in body composition are more
clinically relevant in women leading to diseases such as
osteoporosis, sarcopenia, and diabetes, as women are
more susceptible to these diseases. Thus, any variability
in the aforementioned BC phenotypes or genotypes that
could affect these phenotypes would be of importance for
aging women. A critical point in data interpretation is that
all significant associations found are in agreement; the CC
genotype is representative of reduced IGF1 function,
specifically in women. Admittedly, the experimental
design of the current study could allow false associations
by analyzing numerous phenotypes. Data interpretation
would be difficult if SNP function differed based on race,
sex, or even a particular phenotype. Yet, when all phenotypes were analyzed, Table 3 shows that all associations agree that the lowest IGF1 function occurs in the
CC genotype. The one exception is a higher 1RM for the
CT genotype in the FMS cohort, which might be an age
effect. Regardless, our results indicate seven total associations in women with all seven representing reduced
IGF1 function with the CC genotype and six of seven
being in older women.
In interpreting our results, we note the FMS cohort’s
inconsistency with Hardy–Weinberg equilibrium. Considering our rigorous genotyping controls and validation, the
most likely explanation is a selection bias in recruitment
for the FMS study. Willingness to be involved in a strength
training study whose primary purpose was to uncover
polymorphisms associated with the response to strength
training could cause a selection bias based on an individual’s self-perception and the nature of the study. As the
standard error of the female heterozygotes is very low, it is
unlikely that one or two participants skewed the results.
Additionally, the 7% less than expected number of heterozygotes was identical between male and female participants in FMS. Therefore, we believe a selection bias may
have occurred which could increase the likelihood of type I
error though it seems unlikely in this case due to the
consistency of our findings.
Given the current findings of the CC genotype associating with phenotypes that reflect reduced function of
IGF1, we reexamined the data using a dominant model and
the CC genotype. The only difference from our original
results was a finding of reduced BMD in black males with
the CC genotype and the loss of a statistically significant
association of black females with muscle volume and lean
mass, with all other variables remaining statistically significant. These findings lend support to the hypothesis that
the CC genotype is associated with reduced IGF1 function;
yet, in black women these results suggest that the metabolic effects of reduced IGF1 function drive the association
of fat mass and rs35767. And while direct data comparisons are difficult due to covariance adjustments in our and
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others data sets, our strength data and genotype data are
consistent with previous studies in relative differences
between men and women, old and young, and the overall
effect of the genotype of one gene (Lynch et al. 1999;
Pescatello et al. 2006; Odden et al. 2006). Our results of an
association of rs35767 with phenotypes affected by IGF1
and aging appear consistent with additional recent reports
in women (Canzian et al. 2006; Tamimi et al. 2007).
While, it is possible that another polymorphism in LD
could explain some of these findings, our current data
provide a starting point that can be used for future haplotype analysis in IGF1.
An interpretation of applied functional outcomes is
speculative; however, disease susceptibility or predictability may be the most important use of association
studies. Differences in total lean mass and muscle mass
were approximately 3% greater in the TT genotype group
(black women) when compared to CC which would be
consistent with the loss of muscle that would occur due to
3–4 years of aging in the elderly (Lindle et al. 1997). This
small difference is likely to contribute to an even larger
percentage difference in muscular strength/function (Reid
et al. 2008), and in long term, could result in differences in
physical function and also resting metabolism, obesity,
CAD, diabetes, or CVD. As for BMD, the differences are
substantial, a 5% greater BMD in the TT genotype group as
compared to CC. To interpret, a meta-analysis of 15 clinical trials of calcium supplementation reported only 2.1%
increase in BMD, which results in a 23% reduction in
vertebral fracture risk (Shea et al. 2002), while a study of
36,282 women over 7 years that examined 1,000 mg of Ca
and 400 IU of Vitamin D3 found a 1.06% increase in BMD
and a 29% reduction in hip fracture risk among adherent
subjects (Jackson et al. 2006). Thus the 5% difference
found in the current study could have a substantial impact
on osteoporosis and bone health. A potential application of
the current findings is in preventative medicine, as susceptible women could be identified and interventions
begun sooner.
In conclusion, the current findings appear to indicate a
reduced function of IGF1 in older women associated with
the C allele of rs35767; while most specific to systemic
IGF1 function (BMD, fat, and muscle), is the association in
older black women. To be able to predict health and quality
of life changes with age in a specific population is
important in public health and on an individual basis.
Future studies should target these populations (i.e. women,
specifically black women) to confirm these findings.
Furthermore, studies analyzing the functionality of this
and/or other nearby SNPs is needed before definitive
recommendations can be made based on genotype. Additionally, future haplotype studies are needed and should be
conducted in various ethnic backgrounds.
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